Published on 3 Mar 2024 on Investing.com
Revance sets $100 million stock offering at $6.25 per share
Revance Therapeutics, Inc. (NASDAQ: NASDAQ: RVNC ), a biotechnology firm specializing in aesthetic...
NASDAQ.VTRS price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free